What is the optimal treatment for a patient with concurrent palmoplantar psoriasis and tinea pedis (Fungal infection of the foot)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The optimal treatment for a patient with concurrent palmoplantar psoriasis and tinea pedis is to start with a topical antifungal such as terbinafine 1% cream applied twice daily for 2-4 weeks, or ciclopirox 0.77% cream twice daily for 4 weeks, alongside high-potency topical corticosteroids like clobetasol propionate 0.05% ointment applied twice daily for 2 weeks, then taper to once daily or less frequent application, and consider adding acitretin (10-25mg daily) for moderate-to-severe cases. For the tinea pedis, oral terbinafine 250mg daily for 2 weeks or fluconazole 150mg weekly for 2-4 weeks may be necessary in severe or resistant cases 1. For the palmoplantar psoriasis, combining high-potency topical corticosteroids with a vitamin D analog such as calcipotriene 0.005% ointment can improve efficacy, and for maintenance, consider calcineurin inhibitors like tacrolimus 0.1% ointment 1. It's crucial to treat the fungal infection first or simultaneously, as corticosteroids can worsen tinea infections if used alone. Proper foot hygiene is essential, including keeping feet dry, wearing breathable footwear, and using antifungal powders preventatively. Regular follow-up is important to monitor treatment response and adjust therapy as needed, considering the potential side effects of acitretin, such as benign intracranial hypertension, blurred or decreased night vision, and increased incidence of vulvovaginitis due to Candida albicans 1. In moderate-to-severe cases, systemic therapies may be required, including methotrexate (7.5-25mg weekly), or biologics, and acitretin has been shown to be effective in treating severe psoriasis variants, such as erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar psoriasis 1. The dosage of acitretin should be balanced with the individual patient’s tolerability, with doses ranging from 10 to 50 mg daily, and the major element in dosing acitretin is balancing efficacy with the individual patient’s tolerability 1.

From the Research

Treatment Options for Palmoplantar Psoriasis and Tinea Pedis

  • The optimal treatment for a patient with concurrent palmoplantar psoriasis and tinea pedis is not directly addressed in the provided studies, but some studies suggest treatment options for each condition separately.
  • For palmoplantar psoriasis, topical treatments such as tazarotene cream 2 and calcipotriol-clobetasol propionate combination 3 have been shown to be effective.
  • Excimer lamp therapy has also been found to be effective in treating palmoplantar psoriasis, with similar efficacy to calcipotriol-clobetasol propionate combination 3.
  • For tinea pedis, the provided studies do not offer specific treatment options, but it is generally treated with antifungal medications.

Considerations for Concurrent Treatment

  • When treating a patient with concurrent palmoplantar psoriasis and tinea pedis, it is essential to consider the potential interactions between treatments for each condition.
  • Topical corticosteroids, such as clobetasol propionate, are commonly used to treat palmoplantar psoriasis, but their use may need to be carefully considered in patients with tinea pedis due to the potential for worsening fungal infections 4.
  • The use of antifungal medications to treat tinea pedis may also need to be considered in conjunction with treatments for palmoplantar psoriasis.

Expert Recommendations

  • A narrative review on therapeutic options for palmoplantar pustulosis suggests that topical corticosteroids are a first-line therapy, and oral acitretin is recommended for systemic treatment 5.
  • However, these recommendations may not be directly applicable to patients with concurrent palmoplantar psoriasis and tinea pedis, and treatment should be individualized based on the specific needs of the patient.

Related Questions

Should a biopsy be performed on the rash on the left leg of a patient with a family history of skin cancer, despite improvement with Clobetasol (clobetasol) treatment?
What is the best treatment for a 38-year-old male with worsening contact dermatitis unresponsive to Triamcinolone (triamcinolone)?
What treatment is recommended for a patient with an eczema flare-up who has previously responded well to Clobetasol (clobetasol propionate)?
What is the next best step in managing a persistent rash on the right lower leg in a 57-year-old male patient who had mild relief with triamcinolone (triamcinolone) cream and is now being prescribed clobetasol (clobetasol) BID (twice a day) for two weeks?
What is the next best step in managing a worsening tight foreskin with skin rash in an 81-year-old uncircumcised male after 30 days of clobetasol propionate (clobetasol) 0.05% ointment treatment?
Is Morganella typically sensitive to Flagyl (Metronidazole)?
What is the differential diagnosis for flesh-colored papules, asymptomatic on the dorsum of bilateral feet, unresponsive to one week of hydrocortisone (hydrocortisone) treatment?
What are the implications of having a uric acid level of 9.3, indicating hyperuricemia?
What is the treatment for Helicobacter pylori (H. pylori) infection?
What neurological disorders are associated with Rapid Eye Movement (REM) behavior disorder?
What is the approach to managing hot flashes in an 83-year-old patient with mild cognitive impairment/Alzheimer's disease, who insists on taking oestradiol (estrogen) and progesterone for postmenopausal symptoms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.